We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$36.7B
AUM Growth
+$3.15B
Cap. Flow
+$935M
Cap. Flow %
2.55%
Top 10 Hldgs %
5.15%
Holding
3,891
New
644
Increased
1,079
Reduced
1,381
Closed
771

Sector Composition

Rank Sector Weight
1 Technology 14.3%
2 Consumer Discretionary 12.54%
3 Industrials 10.7%
4 Financials 10.33%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMR icon
3076
Nomura Holdings
NMR
$29.1B
$102K ﹤0.01%
+21,443
New +$102K
NEPT
3077
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$102K ﹤0.01%
+19
New +$91.7K
TRIB
3078
Trinity Biotech
TRIB
$7.47M
$97K ﹤0.01%
162
-95
-37% -$61.9K
VER
3079
DELISTED
VEREIT, Inc.
VER
$97K ﹤0.01%
2,663
AWX icon
3080
Avalon Holdings
AWX
$9.9M
$95K ﹤0.01%
+25,581
New +$94.6K
SRRA
3081
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$92K ﹤0.01%
1,353
-975
-42% -$88.4K
GNW icon
3082
Genworth Financial
GNW
$3.7B
$89K ﹤0.01%
21,459
-3,568
-14% -$16.1K
GV
3083
DELISTED
Goldfield Corporation
GV
$89K ﹤0.01%
20,900
+2,300
+12% +$10.6K
SWN
3084
DELISTED
Southwestern Energy Company
SWN
$88K ﹤0.01%
17,300
-695,502
-98% -$3.69M
NE
3085
CALL
DELISTED
Noble Corporation
NE
$86K ﹤0.01%
+12,300
New +$74.6K
ATYR
3086
aTyr Pharma
ATYR
$51.1M
$84K ﹤0.01%
7,413
+6,499
+711% +$71.1K
BLCM
3087
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$84K ﹤0.01%
+1,361
New +$92.1K
CORV
3088
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$84K ﹤0.01%
+20,823
New +$91.8K
SWN
3089
CALL
DELISTED
Southwestern Energy Company
SWN
$82K ﹤0.01%
16,000
-6,300
-28% -$33.4K
S
3090
DELISTED
Sprint Corporation
S
$77K ﹤0.01%
11,777
MR
3091
DELISTED
Montage Resources Corporation Common Stock
MR
$73K ﹤0.01%
+4,077
New +$93.3K
AVID
3092
DELISTED
Avid Technology Inc
AVID
$69K ﹤0.01%
11,647
-31,787
-73% -$177K
CDTX
3093
DELISTED
Cidara Therapeutics
CDTX
$66K ﹤0.01%
+746
New +$65.8K
EGY icon
3094
Vaalco Energy
EGY
$553M
$64K ﹤0.01%
+23,269
New +$61.3K
ARTX
3095
DELISTED
Arotech Corporation
ARTX
$63K ﹤0.01%
+18,477
New +$66.2K
PETX
3096
DELISTED
Aratana Therapeutics, Inc.
PETX
$62K ﹤0.01%
+10,608
New +$53K
XFOR icon
3097
X4 Pharmaceuticals
XFOR
$392M
$58K ﹤0.01%
+198
New +$84K
FRTX
3098
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$57K ﹤0.01%
132
OMED
3099
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$49K ﹤0.01%
22,938
-4,956
-18% -$11.9K
CRIS icon
3100
Curis
CRIS
$8.79M
$46K ﹤0.01%
64
-25
-28% -$16.3K

Similar funds

Two Sigma Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Two Sigma Investments held 3,891 positions worth $36.7B, up 9.4% from $33.5B the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.

Two Sigma Investments's Q3 2018 filing shows 644 new, 1,079 increased, 1,381 reduced and 771 closed positions. Its largest new stake was Royal Caribbean: 1,011,770 shares worth $131M. The largest sale was Burlington, an estimated $168M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Two Sigma Investments's largest Q3 2018 buy was Royal Caribbean: 1,011,770 shares worth $131M.
  • Two Sigma Investments added most to Boeing in Q3 2018, an estimated $159M increase.
  • Two Sigma Investments's biggest Q3 2018 reduction was Burlington, cutting an estimated $168M.
  • Two Sigma Investments fully exited Align Technology in Q3 2018, selling an estimated $116M.
  • Two Sigma Investments's ten largest holdings make up 5.1% of its $36.7B portfolio in Q3 2018.
  • Two Sigma Investments opened 644 new positions and closed 771 in Q3 2018.
  • Two Sigma Investments's portfolio value rose 9.4% quarter-over-quarter to $36.7B.

Based on Two Sigma Investments's 13F filing for Q3 2018, filed 14 Nov 2018.